Delivery Order SPE2DB20D3103-SPE2DB25FQ0G1
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $7,966.52 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $165,523.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, which was not set-aside and competitively awarded, is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $43,115.10 delivery order to AmerisourceBergen Drug Corp for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine product. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, non-set-aside award executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed in...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,197.92 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a competitively awarded non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $20,877.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Menveo (meningococcal vaccine) in single-dose vial formulation (0.5 mL). This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $61,593 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill the delivery order from its corporate office location. This contract...
- The Defense Logistics Agency awarded a $79,278.21 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed-price contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The place of performance is the company's corporate...
- The Defense Logistics Agency awarded a $4,383.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Menveo 1 Vial (A-C-Y-W-135-DIP) 0.5ML, a meningococcal conjugate vaccine. The contract has an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded. As a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0G1Delivery Order
The Defense Logistics Agency awarded a $237,587.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 vial (meningococcal conjugate vaccine) with completion targeted for August 27, 2025. This non-set-aside award, issued on August 26, 2025, represents a single delivery order fulfillment from AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and serves as a major healthcare solutions provider and pharmaceutical distributor for federal medical procurement. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates extensive experience supplying vaccines, specialty medications, and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The vaccine delivery supports DLA's medical supply chain operations and contributes to the broader federal pharmaceutical procurement mission serving military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $237.6k | 8/26/25 |